Effect of Delayed Clozapine Initiation on Acute Treatment Response in Treatment-Resistant Schizophrenia

Korean Journal of Schizophrenia Research Pub Date : 2021-10-30 DOI:10.16946/kjsr.2021.24.2.52

Soyung Yang, Jung-Kyu Choi, Sunyoung Park, Jaesub Park

引用次数: 0

Abstract

클로자핀(clozapine)은 TRS 환자에게서 유의한 효과를 보 인 유일한 약물이며, 치료 반응률은 연구마다 다양하나 대 체로 30%-60% 정도로 보고되고 있다. 클로자핀은 다른 Received: May 20, 2021 / Revised: June 4, 2021 Accepted: July 6, 2021 Address for correspondence: So Yung Yang, Department of Psychiatry, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea Tel: 031-900-3562, Fax: 031-900-0343 E-mail: soryul@naver.com 본 연구는 국민건강보험 일산병원의 연구비 지원으로 이루어졌음(NHIMC20 20CR078). 클로자핀의 지연된 사용이 치료저항성 조현병 환자의 급성기 약물 반응에

查看原文本刊更多论文

延迟氯氮平起始治疗对难治性精神分裂症急性治疗反应的影响

氯氮平(clozapine)是TRS患者中唯一有显著疗效的药物，每个研究的治疗反应率都是30%-60%。氯芬是另一种Received: May 20, 2021 / Revised: June 4, 2021 Accepted: July 6, 2021 Address for correspondence:So Yung Yang, Department of Psychiatry, National Health Insurance Service Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444, Korea Tel: 031-900-3562, Fax: 031-900-0343 E-mail:soryul@naver.com本研究由国民健康保险一山医院的研究经费资助(NHIMC20 20CR078)。氯氮平的延迟使用对治疗抵抗性精神分裂症患者的急性期药物反应

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Korean Journal of Schizophrenia Research

自引率

0.00%

发文量